{"title":"Translating the m6A epitranscriptome for prostate cancer","authors":"Qian Tao, Qian Zhang","doi":"10.1038/s41585-025-01054-2","DOIUrl":"https://doi.org/10.1038/s41585-025-01054-2","url":null,"abstract":"Mapping the N6-methyladenosine (m6A) transcriptome in prostate cancer has established its clinical potential value as a prognostic biomarker for this disease. A multidisciplinary approach that integrates genomics, transcriptomics, epitranscriptomics, proteomics and clinical oncology is essential to translate the intricacies of m6A modification into tangible benefits for patients","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"522 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144238137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hannah E. Lyons, Andrew Peel, Macarena Gonzalez, Josh Deluao, Oluwabunmi Olatunji, Victoria Nikitaras, Nicole O. McPherson
{"title":"Unlocking the power of semen analysis in primary health care — a path to men’s health and lifestyle transformation","authors":"Hannah E. Lyons, Andrew Peel, Macarena Gonzalez, Josh Deluao, Oluwabunmi Olatunji, Victoria Nikitaras, Nicole O. McPherson","doi":"10.1038/s41585-025-01047-1","DOIUrl":"https://doi.org/10.1038/s41585-025-01047-1","url":null,"abstract":"<p>Declining fertility, overlooked mental health, and reduced life expectancy underscore the urgent need for renewed attention to men’s health. A semen analysis, traditionally used to assess fertility, holds untapped potential as a tool for promoting lifestyle changes and preventing chronic diseases in men. Spermatogenesis is highly sensitive to environmental and lifestyle factors and can be an early indicator of overall health. Disruptions in this process can signal underlying systemic issues and predict long-term health risks, including cardiovascular disease and metabolic disorders. An increasing number of men seek to engage in preconception care, as fertility is closely tied to a man’s sense of masculinity, identity and aspirations for fatherhood. In this context, a semen analysis can be a powerful motivator to encourage healthy behaviours and proactive health management. By incorporating semen analysis into primary care, health care providers can leverage men’s desire for fatherhood as an entry point to discuss broader health concerns, such as mental well-being, nutrition and physical activity. This approach would address immediate reproductive health, and also promote long-term wellness, helping to reduce the burden of chronic disease in men.</p>","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"10 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144228902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mitochondrial dysfunction as a crucial mediator of ADT-induced cardiovascular risk","authors":"Yu-Hsiang Lin, Kuo-Jen Lin, Horng-Heng Juang","doi":"10.1038/s41585-025-01050-6","DOIUrl":"https://doi.org/10.1038/s41585-025-01050-6","url":null,"abstract":"<p>We read with great interest the recent Review article by Tisseverasinghe et al.<sup>1</sup>, which offers a comprehensive overview of cardiovascular risks associated with various prostate cancer therapies, including androgen deprivation therapy (ADT) (Assessing the effects of prostate cancer therapies on cardiovascular health. <i>Nat. Rev. Urol.</i> https://doi.org/10.1038/s41585-025-01002-0; 2025). We wish to highlight an additional perspective, according to which mitochondrial dysfunction is likely to be a central mechanism bridging ADT to the diverse cardiometabolic sequelae.</p><p>Accumulating evidence indicates that low testosterone levels induce oxidative stress and impair mitochondrial function<sup>2</sup>. Mitochondria, the cell’s powerhouse, regulate ATP production, redox balance and apoptosis. Perturbations in these processes during testosterone suppression might explain the heightened risk of atherosclerosis, QT prolongation and heart failure in men receiving ADT<sup>3,4</sup>. Indeed, cardiomyocytes are known to depend heavily on efficient mitochondrial ATP synthesis, and even subtle mitochondrial impairment can precipitate electrical instability (leading to arrhythmias) and structural remodelling (promoting cardiomyopathies)<sup>4</sup>.</p>","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"7 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144228903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Steven Tisseverasinghe, Marwan Tolba, Boris Bahoric, Fred Saad, Tamim Niazi
{"title":"Reply to ‘Mitochondrial dysfunction as a crucial mediator of ADT-induced cardiovascular risk’","authors":"Steven Tisseverasinghe, Marwan Tolba, Boris Bahoric, Fred Saad, Tamim Niazi","doi":"10.1038/s41585-025-01049-z","DOIUrl":"https://doi.org/10.1038/s41585-025-01049-z","url":null,"abstract":"<p>We appreciate the thoughtful comments from Yu-Hsiang Lin et al. regarding our Review article (Assessing the effects of prostate cancer therapies on cardiovascular health. <i>Nat. Rev. Urol.</i> https://doi.org/10.1038/s41585-025-01002-0; 2025)<sup>1</sup>. In their Correspondence (Mitochondrial dysfunction as a crucial mediator of ADT-induced cardiovascular risk. <i>Nat. Rev. Urol.</i> https://doi.org/10.1038/s41585-025-01050-6; 2025)<sup>2</sup>, the authors highlight the potential role of mitochondrial dysfunction as a unifying mechanism underlying the diverse systemic effects of androgen deprivation therapy (ADT), including cardiovascular, metabolic and neurocognitive complications.</p><p>We agree that mitochondrial dysfunction is indeed a possible understudied contributor to ADT-induced cardiotoxicity. As Lin et al. note, low testosterone levels have been linked to oxidative stress and impaired mitochondrial function, which could contribute to conditions such as atherosclerosis, arrhythmias and heart failure<sup>3,4</sup>. These observations are further supported by preclinical and clinical evidence suggesting that ADT disrupts processes heavily reliant on mitochondrial integrity, including cellular energy metabolism, redox balance and apoptosis pathways<sup>5,6</sup>. Beyond cardiovascular effects, we also agree that mitochondrial dysfunction might potentially have a role in the progression of castration-resistant prostate cancer and ADT-associated neurocognitive decline. The observed shift towards aerobic glycolysis, often referred to as the Warburg effect, in prostate cancer cells under ADT might suggest a possible role for mitochondrial regulation in both oncogenesis and treatment resistance<sup>7</sup>.</p>","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"39 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144228904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Molecular imaging of renal cell carcinomas: ready for prime time.","authors":"Qianyun Wu, Hongda Shao, Wei Zhai, Gang Huang, Jianjun Liu, Jeremie Calais, Weijun Wei","doi":"10.1038/s41585-024-00962-z","DOIUrl":"10.1038/s41585-024-00962-z","url":null,"abstract":"<p><p>The clinical diagnosis of renal cell carcinoma (RCC) is constantly evolving. Diagnostic imaging of RCC relying on enhanced computed tomography (CT) and magnetic resonance imaging (MRI) is commonly used for renal mass characterization and assessment of tumour thrombosis, whereas pathology is the gold standard for establishing diagnosis. However, molecular imaging is rapidly improving the clinical management of RCC, particularly clear-cell RCC. Molecular imaging aids in the non-invasive visualization and characterization of specific biomarkers such as carbonic anhydrase IX and CD70 within the tumours, which help to assess tumour heterogeneity and status. Target-specific molecular imaging of RCCs will substantially improve the diagnostic landscape of RCC and will further facilitate clinical decision-making regarding initial staging and re-staging, monitoring of recurrence and metastasis, patient stratification and selection, and the prediction and evaluation of treatment responses.</p>","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":" ","pages":"336-353"},"PeriodicalIF":12.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicholas T. H. Farr, Pascal Achenbach, Karl-Dietrich Sievert
{"title":"Effects of degradation-associated polypropylene particles in the surrounding tissue after surgical mesh implantation","authors":"Nicholas T. H. Farr, Pascal Achenbach, Karl-Dietrich Sievert","doi":"10.1038/s41585-025-01046-2","DOIUrl":"https://doi.org/10.1038/s41585-025-01046-2","url":null,"abstract":"Evidence of polypropylene mesh degradation has revealed particle accumulation in surrounding tissues, raising concerns about potential local and systemic immune responses. Associations between polypropylene degradation and autoimmune/autoinflammatory syndrome induced by adjuvants-like symptoms have been made, and vigilant clinical assessment is important, especially in patients with a predisposition for allergy or autoimmune diseases.","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"133 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144123005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pride, not prejudice","authors":"","doi":"10.1038/s41585-025-01053-3","DOIUrl":"https://doi.org/10.1038/s41585-025-01053-3","url":null,"abstract":"In June 2020, at the height of the COVID-19 lockdown, Nature Reviews Urology published its first Pride special issue. At the time, we were the first urology journal and the first Nature Reviews journal to produce special content for Pride. Since then, numerous journals have followed suit and highlighted the importance of inclusion and understanding of underserved populations in medicine.","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"8 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144113972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Synergistic targeting strategies for prostate cancer.","authors":"Xuanji Li,Zeyu Han,Jianzhong Ai","doi":"10.1038/s41585-025-01042-6","DOIUrl":"https://doi.org/10.1038/s41585-025-01042-6","url":null,"abstract":"Prostate cancer is the second most commonly diagnosed cancer and the fifth leading cause of death among men worldwide. Androgen deprivation therapy is a common prostate cancer treatment, but its efficacy is often hindered by the development of resistance, which results in reducing survival benefits. Immunotherapy showed great promise in treating solid tumours; however, clinically significant improvements have not been demonstrated for patients with prostate cancer, highlighting specific drawbacks of this therapeutic modality. Hence, exploring novel strategies to synergistically enhance the efficacy of prostate cancer immunotherapy is imperative. Clinical investigations have focused on the combined use of targeted or gene therapy and immunotherapy for prostate cancer. Notably, tumour-specific antigens and inflammatory mediators are released from tumour cells after targeted or gene therapy, and the recruitment and infiltration of immune cells, including CD8+ T cells and natural killer cells activated by immunotherapy, are further augmented, markedly improving the efficacy and prognosis of prostate cancer. Thus, immunotherapy, targeted therapy and gene therapy could have reciprocal synergistic effects in prostate cancer in combination, resulting in a proposed synergistic model encompassing these three therapeutic modalities, presenting novel potential treatment strategies for prostate cancer.","PeriodicalId":19088,"journal":{"name":"Nature Reviews Urology","volume":"88 1","pages":""},"PeriodicalIF":15.3,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144103813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}